Document Detail


Percutaneous management of chronic critical limb ischemia.
MedLine Citation:
PMID:  21803228     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Critical limb ischemia (CLI) is primarily a disease of advanced atherosclerosis but may occur in the setting of other causes. It is essential for the treating physician to understand the complexity of patients with CLI and the appropriate and emerging treatment approaches in this patient population. The authors provide a comprehensive review of the percutaneous endovascular management of CLI in this article.
Authors:
Aravinda Nanjundappa; Akhilesh Jain; Kevin Cohoon; Robert S Dieter
Related Documents :
3255488 - Ambulatory treatment by extracorporeal shock wave lithotripsy for an urethral stone in ...
2017818 - Evaluation and management of incontinence after implantation of the artificial urinary ...
15461918 - Sling failures: what's next?
18481668 - Survey of organizational job stress among physical education managers.
15676648 - The psychology of personal information management.
20369128 - Sports related concussion - management in general practice.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cardiology clinics     Volume:  29     ISSN:  1558-2264     ISO Abbreviation:  Cardiol Clin     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-08-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8300331     Medline TA:  Cardiol Clin     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  395-410     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Division of Vascular Surgery, West Virginia University, 3100 McCorkle Avenue SE, Charleston, WV 25304, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recent advances in percutaneous management of iliofemoral and superficial femoral artery disease.
Next Document:  Update on biological therapies for critical limb ischemia.